Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
24.44
-0.18 (-0.73%)
At close: Jan 28, 2026, 4:00 PM EST
24.37
-0.07 (-0.29%)
Pre-market: Jan 29, 2026, 8:39 AM EST
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $2.35 billion as of January 29, 2026. Its market cap has decreased by -40.95% in one year.
Market Cap
2.35B
Enterprise Value
2.77B
1-Year Change
-40.95%
Ranking
Category
Stock Price
$24.44
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $2.35B, an increase of 97.97%. That is a compound annual growth rate of 5.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 2.36B | 6.26% |
| Dec 31, 2025 | 2.22B | -42.88% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spyre Therapeutics | 2.51B |
| Wave Life Sciences | 2.42B |
| Sarepta Therapeutics | 2.39B |
| Recursion Pharmaceuticals | 2.39B |
| Mesoblast | 2.38B |
| Ocular Therapeutix | 2.32B |
| Ascentage Pharma Group International | 2.32B |
| Soleno Therapeutics | 2.30B |